Myrelid 2014.
Study characteristics | ||
Methods | Retrospective cohort. Study period not provided | |
Participants | Country: Sweden. CD patients who underwent resection with primary anastomoses and/or stirctureplasties. Patients with stomas were excluded | |
Interventions | 1. Preoperative infliximab (n= 111) within 2 months of surgery 2. No preoperative infliximab (n= 187) |
|
Outcomes | Infectious complications within 30 days of surgery | |
Notes | NOS very high risk of bias overall Unadjusted ORs for preoperative steroids, immunomodulators and anti‐TNF were o btained from regression analysis. |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Representativeness of the exposed cohort | Low risk | CD patients who underwent resection with primary anastomoses and/or stirctureplasties. |
Selection of the non exposed cohort | Low risk | Both groups obtained from the same hospital database and time period |
Ascertainment of exposure | Low risk | Data obtained from database |
Demonstration that outcome of interest was not present at start of study | High risk | Indication for surgery was abscess/fistula in 61 patients |
Comparability of cohorts (Controlled for critical factor/other medications) | High risk | Univariate analysis |
Comparability of cohorts (Controlled for additional factor) | High risk | Univariate analysis |
Assessment of outcome | Low risk | Data obtained from database |
Was follow‐up long enough for outcomes to occur | Low risk | 30 days |
Adequacy of follow up of cohorts | Unclear risk | No information provided |